Continuous Adductor Canal Block Reduces Opioid Use After Total Knee Arthroplasty

Recent findings presented at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in New Orleans suggest that the use of a continuous adductor canal block after TKA (total knee arthroplasty) may significantly enhance the early stages of patient recovery. The data indicates that this specific pain management approach can improve overall recovery and pain scores while reducing the reliance on opioid medications during the critical first 72 hours following surgery.

For patients undergoing total knee replacement, the immediate postoperative period is often defined by the challenge of balancing effective pain relief with the need for early mobilization. The shift toward multimodal pain control—using a combination of different medications and techniques to target pain from multiple angles—aims to minimize the side effects associated with heavy opioid use, such as nausea, sedation, and the risk of dependency.

Dr. Jesse I. Wolfstadt, the Granovsky Gluskin Chair in Orthopaedic Reconstruction at Mount Sinai Hospital and the University of Toronto, highlighted that these results are pivotal for the evolution of surgical aftercare. According to Dr. Wolfstadt, these findings will help inform more standardized multimodal pathways for pain control for patients undergoing joint replacement.

Improving Postoperative Outcomes and Opioid Reduction

The primary objective of utilizing a continuous adductor canal block is to provide targeted anesthesia to the knee joint while preserving the motor function of the quadriceps muscle, which is essential for walking and physical therapy. By delivering a steady stream of analgesic medication through a catheter, surgeons can potentially maintain a more consistent level of pain relief than is possible with single-shot injections.

The results presented in New Orleans specifically pointed to improvements in pain scores and a decrease in opioid consumption within the first 72 hours post-surgery. This window is critical for patients, as early movement is a cornerstone of rapid recovery protocols, helping to prevent complications such as deep vein thrombosis and joint stiffness.

By integrating this technique into a broader multimodal strategy, healthcare providers aim to create a more predictable and efficient recovery trajectory. This approach aligns with the broader medical goal of reducing the systemic use of opioids in orthopedic surgery, focusing instead on localized and non-opioid alternatives to manage acute pain.

Expertise in Complex Orthopaedic Reconstruction

The research is led by Dr. Jesse Wolfstadt, a fellowship-trained orthopaedic surgeon who specializes in complex primary and revision knee replacements. Dr. Wolfstadt currently serves as the Division Head of Orthopaedic Surgery and holds the Granovsky Gluskin Chair in Orthopaedics Reconstruction at Mount Sinai Hospital in Toronto, Ontario, Canada via Sinai Health.

Dr. Wolfstadt’s academic and clinical background is deeply rooted in both surgical precision and systemic quality improvement. He earned his MD from the University of Toronto in 2011 and completed his orthopaedic surgery residency there in 2016. To further his expertise in patient outcomes, he obtained a Master of Science in Quality Improvement and Patient Safety from the University of Toronto’s Institute for Health Policy, Management and Evaluation in 2017 via UofT Division of Orthopaedic Surgery.

His extensive fellowship training spans multiple institutions and specialties, including:

• Complex adult lower extremity reconstruction at Mount Sinai Hospital.
• Traumatology and arthroplasty at St. Michael’s Hospital.
• Additional traumatology training at Auckland City Hospital in New Zealand.

In addition to his clinical practice, Dr. Wolfstadt is an Assistant Professor and Surgeon-Investigator. His research focuses on improving the efficiency and quality of care for joint replacement and trauma patients through interprofessional and patient-centered co-design. This focus on “co-design” ensures that the patient’s experience and needs are integrated into the medical protocols developed by surgeons and nurses.

Toward Standardized Multimodal Pain Pathways

The ultimate goal of presenting these findings at the AAOS Annual Meeting is to move toward a global standardization of care. Currently, pain management protocols can vary significantly between hospitals and individual surgeons. By establishing evidence-based “multimodal pathways,” the medical community can ensure that every patient receives a optimized combination of therapies tailored to the specific demands of total knee arthroplasty.

These pathways typically involve a combination of:

• Local Anesthetics: Such as the continuous adductor canal block, to numb the surgical site.
• Non-Opioid Systemic Medications: Including anti-inflammatories and acetaminophen.
• Patient-Centered Protocols: Rapid recovery and ERAS (Enhanced Recovery After Surgery) protocols designed to get patients mobile as quickly as possible.

Dr. Wolfstadt has previously collaborated on initiatives to enhance these systems, including the development of regional anesthesia programs and the establishment of outpatient total joint arthroplasty programs. His ongoing work as a co-principal investigator on peer-reviewed grants continues to examine the intersections of pain control, infection rates, and fractures following knee replacement surgery.

Key Takeaways for Patients and Providers

• Reduced Opioids: Continuous adductor canal blocks may lower the need for opioid painkillers in the first three days after TKA.
• Better Pain Scores: Patients may experience more manageable pain levels during the early recovery phase.
• Faster Recovery: Targeted anesthesia helps maintain muscle function, facilitating earlier mobilization.
• Standardization: This research supports the creation of uniform, multimodal pain management protocols across orthopedic practices.

As orthopedic surgery continues to evolve toward outpatient and rapid-recovery models, the integration of advanced regional anesthesia like the continuous adductor canal block represents a significant step in improving the patient experience and safety. The focus remains on maximizing functional recovery while minimizing the pharmacological burden on the patient.

Further updates on the implementation of these multimodal pathways are expected as more institutions adopt the findings presented at the AAOS Annual Meeting. Patients seeking more information on joint replacement recovery options are encouraged to consult with their surgical team regarding the latest regional anesthesia protocols.

We invite readers to share their experiences with joint replacement recovery or ask questions about new pain management protocols in the comments below.